Ansbert Gadicke, Director, 10% Owner at TCR2 THERAPEUTICS INC. (TCRR), sold 140,340 shares at $1.88 ($264K) on 2023-05-22, disclosed to the SEC on 2023-05-24.
Open-market sale of $264k TCRR by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.88 | 70,170 | $132K | 50.0% |
| 2 | $1.88 | 70,170 | $132K | 50.0% |
| Total | $1.88 avg | 140,340 | $264K | 100% |
| Filing → |
| ITOS | SELL | 2021-10-14 | $5.2M | — | Filing → |
| ITOS | SELL | 2021-10-05 | $2.2M | — | Filing → |
| ITOS | SELL | 2021-09-23 | $3.1M | — | Filing → |